Buchang Pharmaceutical announced that the company previously disclosed that its holding subsidiary Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. plans to increase capital and expand shares to introduce external investors. The company relinquishes priority subscription rights and assumes repurchase obligations. Recently, Luzhou Buchang completed the industrial and commercial change registration procedures for the capital increase mentioned above, and obtained a business license issued by the Luxian Market Supervision Administration. The registered capital is 100 million yuan. The registered capital is 100 million yuan. After this change, the company held 92.3641% of Luzhou Buchang's shares.

Buchang Pharmaceutical announced that the company previously disclosed that its holding subsidiary Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. plans to increase capital and expand shares to introduce external investors. The company relinquishes priority subscription rights and assumes repurchase obligations. Recently, Luzhou Buchang completed the industrial and commercial change registration procedures for the capital increase mentioned above, and obtained a business license issued by the Luxian Market Supervision Administration. The registered capital is 100 million yuan. The registered capital is 100 million yuan. After this change, the company held 92.3641% of Luzhou Buchang's shares.